Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pintor

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Heliyon|October 27, 2023
Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsyE Monteagudo-Gimeno, R Sánchez-González, J Raduà-Castaño, et al.
Epilepsy & Behavior : E&B|May 16, 2023
Clinical relevance of interictal dysphoric disorder and its impact on quality of life in drug-resistant epilepsyE Monteagudo-Gimeno, R Sánchez-González, J Raduà-Castaño, et al.
Heliyon|June 19, 2025
Corrigendum to "Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy" [Heliyon Volume 9, Issue 10, October 2023, Article e20903]E Monteagudo-Gimeno, R Sánchez-González, J Raduà-Castaño, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Heliyon|October 27, 2023
Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsyE Monteagudo-Gimeno, R Sánchez-González, J Raduà-Castaño, et al.
Epilepsy & Behavior : E&B|May 16, 2023
Clinical relevance of interictal dysphoric disorder and its impact on quality of life in drug-resistant epilepsyE Monteagudo-Gimeno, R Sánchez-González, J Raduà-Castaño, et al.
Heliyon|June 19, 2025
Corrigendum to "Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy" [Heliyon Volume 9, Issue 10, October 2023, Article e20903]E Monteagudo-Gimeno, R Sánchez-González, J Raduà-Castaño, et al.
Pageof 4